Drug intelligence / Profile preview

Innovag

Development stage: Unknown
Lead developer: INNventa Pharm
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Vaginal

Overview

Innovag is a gynecological product developed by INNventa Pharm, primarily marketed as a medical device in the form of vaginal ovules or gel. It is designed to restore and maintain the physiological balance of the vaginal environment by regulating pH and supporting the natural microflora. The formulation typically contains lactic acid, which helps lower the vaginal pH to its natural acidic state, and probiotics such as *Lactobacillus acidophilus* to inhibit the growth of pathogenic microorganisms. Additionally, it often includes sodium hyaluronate to hydrate and protect the vaginal mucosa. Innovag is used as an adjuvant in the treatment and prevention of bacterial vaginosis, vaginal candidiasis, and non-specific vaginitis.

Brand names: Innovag

Beyond the preview

Go deeper on Innovag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovag.

Explore the full profile